Biliary lipid secretion in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia. Influence of bezafibrate and fenofibrate.
Open Access
- 1 September 1988
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 27 (7) , 713-723
- https://doi.org/10.1016/s0022-2275(20)38795-2
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Effect of ciprofibrate treatment on biliary lipids in patients with hyperlipoproteinaemiaEuropean Journal of Clinical Investigation, 1984
- Defective Lipoprotein Receptors and AtherosclerosisNew England Journal of Medicine, 1983
- Mechanism of Cholesterol Gallstones FormationSeminars in Liver Disease, 1983
- Reduction of Serum Cholesterol in Heterozygous Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1983
- Cholesterol Crystals and the Formation of Cholesterol GallstonesNew England Journal of Medicine, 1980
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980
- ColestipolDrugs, 1980
- Clofibrate therapy and gallstone inductionDigestive Diseases and Sciences, 1978
- Gallbladder Disease as a Side Effect of Drugs Influencing Lipid Metabolism Experience in the Coronary Drug ProjectNew England Journal of Medicine, 1977
- Effect of phenobarbital on bile flow and bile salt excretion in the ratNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1971